Evidence map›Paper›PMID 35242566›Full record

ArticleMolecular genetics and metabolism reports2022

Hematopoietic cell transplantation for sialidosis type I.

Ashish O Gupta, Marc C Patterson, Tim Wood, Julie B Eisengart, Paul J Orchard, Troy C Lund

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular genetics and metabolism reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Ashish O GuptaDivision of Pediatric Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN 55455, United States of America.
Marc C PattersonDivision of Child and Adolescent Neurology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
Tim WoodBiochemical Genetics Laboratory, Greenwood Genetic Center, Greenwood, SC 29646, United States of America.
Julie B EisengartDepartment of Pediatrics, Division of Clinical Behavioral Neuroscience, University of Minnesota, Minneapolis, MN, USA.
Paul J OrchardDivision of Pediatric Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN 55455, United States of America.
Troy C LundDivision of Pediatric Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN 55455, United States of America.
University of Minnesota · USGreenwood Genetic Center · USMayo Clinic · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report the clinical and laboratory follow-up data of an adolescent female with Type I Sialidosis who underwent bone marrow transplant (BMT). After BMT, plasma and urine biomarkers responded concurrently with engraftment. Neuropsychiatry data showed preservation in some domains, but she did have overall decline in motor performance. Sialidosis is a very rare lysosomal condition, and we believe this to be the first report of a case of Type I Sialidosis undergoing BMT.

Indexed as

Blood and marrow transplantationCherry-red spot myoclonus syndromeHematopoietic cell transplantationSialidosis, type I

Identifiers

PMID35242566
PMCPMC8856904
OpenAlexW4200471241

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.